ClinicalTrials.Veeva

Menu

Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

Alcon logo

Alcon

Status

Completed

Conditions

Contact Lens Care

Treatments

Device: Soft contact lenses
Device: Hydrogen peroxide-based contact lens care system
Device: PHMB-containing contact lens solution

Study type

Interventional

Funder types

Industry

Identifiers

NCT01494818
ID 10-59 / M-11-02

Details and patient eligibility

About

The purpose of this study was to assess and compare the effect of the repeated usage of two different contact lens care systems (one hydrogen peroxide-based cleaning and disinfecting system, and one polyaminopropyl biguanide (PHMB)-containing multipurpose system) with silicone hydrogel contact lenses worn on a daily wear basis for three months. The specific aspect of interest was the effect on the ocular tissue, in particular the eyelids and their associations with the contact lens surface wettability and surface contamination.

Full description

The subjects attended the enrollment visit having worn their habitual silicone hydrogel contact lenses for at least six hours on the day of the visit. The enrollment visit was scheduled so that the subjects' habitual lenses were at least 14 ± 3 days old for the subjects replacing their lenses bi-weekly and at least 30 ± 5 days old for those replacing their lenses monthly.

Enrollment

79 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Read and understand Participant Information Sheet;
  • Read, sign, and date Informed Consent;
  • Successfully wearing silicone hydrogel contact lenses under a frequent replacement (biweekly or monthly) daily wear modality;
  • Using a PHMB-containing multipurpose contact lens solution;
  • Symptomatic, as specified in protocol;
  • Best corrected visual acuity of 6/9 or better in each eye;
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Any known sensitivity or intolerance to the contact lenses or len care products to be used;
  • Systemic disease/medication which might interfere with contact lens wear or produce dry eye side effects;
  • Ocular allergies or ocular disease which might interfere with contact lens wear;
  • Use of any concomitant topical ocular medications during the study period;
  • Participation in an investigational drug or device study within 30 days of entering the study;
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

79 participants in 2 patient groups

CLEAR CARE/AOSEPT Plus
Experimental group
Description:
Hydrogen peroxide-based contact lens care system used per manufacturer's instructions
Treatment:
Device: Hydrogen peroxide-based contact lens care system
Device: Soft contact lenses
ReNu MultiPlus
Active Comparator group
Description:
PHMB-containing contact lens solution used per manufacturer's instructions
Treatment:
Device: PHMB-containing contact lens solution
Device: Soft contact lenses

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems